<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine whether antithrombin-III (AT-III) deficiency leads to an excess mortality, we studied 171 individuals from ten families with a proven hereditary deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>73 were classified as certainly deficient either by direct measurement of AT-III concentration or by mendelian <z:hpo ids='HP_0000005'>inheritance</z:hpo> patterns </plain></SENT>
<SENT sid="2" pm="."><plain>98 individuals had a high probability (0.5) of deficiency </plain></SENT>
<SENT sid="3" pm="."><plain>The 64 <z:hpo ids='HP_0011420'>deaths</z:hpo> recorded did not exceed those expected for the general population adjusted for age, sex, and calendar period </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that a policy of prophylactic anticoagulation for patients with AT-III deficiency cannot be recommended </plain></SENT>
</text></document>